Studienserver - Medizinische Hochschule Hannover

Studies: InductionChemo-Radio-Antibody-Treatment

ID Trial

EudraCT number

Clinicaltrials.gov identifier

Description

Randomized Phase II Study of two different protocols of TPF induction chemotherapy regimen followed by radiation therapy plus Cetuximab (TPF-HART-CET) vs. HART plus Cisplatinum (CIS-HART) in patients with locally advanced unresectable squamous cell carcinomas of the head and neck

Status